BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31558788)

  • 1. EASIX and mortality after allogeneic stem cell transplantation.
    Luft T; Benner A; Terzer T; Jodele S; Dandoy CE; Storb R; Kordelas L; Beelen D; Gooley T; Sandmaier BM; Sorror M; Zeisbrich M; Radujkovic A; Dreger P; Penack O
    Bone Marrow Transplant; 2020 Mar; 55(3):553-561. PubMed ID: 31558788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
    Penack O; Luft T; Peczynski C; Benner A; Sica S; Arat M; Itäla-Remes M; Corral LL; Schaap NPM; Karas M; Raida L; Schroeder T; Dreger P; Metafuni E; Ozcelik T; Sandmaier BM; Kordelas L; Moiseev I; Schoemans H; Koenecke C; Basak GW; Peric Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation.
    Acosta-Medina AA; Baranwal A; Johnson IM; Kharfan-Dabaja MA; Murthy H; Palmer JM; Sproat L; Mangaonkar A; Shah MV; Hogan WJ; Litzow MR; Tefferi A; Alkhateeb HB
    Transplant Cell Ther; 2023 Jun; 29(6):360.e1-360.e8. PubMed ID: 36773650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.
    Luft T; Benner A; Jodele S; Dandoy CE; Storb R; Gooley T; Sandmaier BM; Becker N; Radujkovic A; Dreger P; Penack O
    Lancet Haematol; 2017 Sep; 4(9):e414-e423. PubMed ID: 28733186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel.
    Jiang S; Penack O; Terzer T; Schult D; Majer-Lauterbach J; Radujkovic A; Blau IW; Bullinger L; Müller-Tidow C; Dreger P; Luft T
    Haematologica; 2021 Feb; 106(2):446-453. PubMed ID: 31974195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EASIX-1year and late mortality after allogeneic stem cell transplantation.
    Kordelas L; Terzer T; Gooley T; Davis C; Sandmaier BM; Sorror M; Penack O; Schaeper NDE; Blau IW; Beelen D; Radujkovic A; Dreger P; Luft T
    Blood Adv; 2023 Sep; 7(18):5374-5381. PubMed ID: 37477588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
    Pedraza A; Salas MQ; Rodríguez-Lobato LG; Escribano-Serrat S; Suárez-Lledo M; Martínez-Cebrian N; Solano MT; Arcarons J; Rosiñol L; Gutiérrez-García G; Fernández-Avilés F; Moreno-Castaño AB; Molina P; Pino M; Carreras E; Díaz-Ricart M; Rovira M; Palomo M; Martínez C
    Transplant Cell Ther; 2024 Feb; 30(2):187.e1-187.e12. PubMed ID: 38000709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
    Varma A; Rondon G; Srour SA; Chen J; Ledesma C; Champlin RE; Ciurea SO; Saliba RM
    Biol Blood Marrow Transplant; 2020 May; 26(5):1013-1020. PubMed ID: 32045652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation.
    Peña M; Salas MQ; Mussetti A; Moreno-Gonzalez G; Bosch A; Patiño B; Jiménez L; Kara M; Parody R; Sureda A
    Blood Adv; 2021 Sep; 5(17):3418-3426. PubMed ID: 34495311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
    Sanchez-Escamilla M; Flynn J; Devlin S; Maloy M; Fatmi SA; Tomas AA; Escribano-Serrat S; Ponce D; Sauter CS; Giralt SA; Scordo M; Perales MA
    Bone Marrow Transplant; 2023 May; 58(5):498-505. PubMed ID: 36721042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EASIX for prediction of survival in lower-risk myelodysplastic syndromes.
    Merz A; Germing U; Kobbe G; Kaivers J; Jauch A; Radujkovic A; Hummel M; Benner A; Merz M; Dreger P; Luft T
    Blood Cancer J; 2019 Nov; 9(11):85. PubMed ID: 31712595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
    Song GY; Jung SH; Kim K; Kim SJ; Yoon SE; Lee HS; Kim M; Ahn SY; Ahn JS; Yang DH; Kim HJ; Lee JJ
    BMC Cancer; 2020 Aug; 20(1):803. PubMed ID: 32831058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Yegin ZA; Savaş EM; Yıldız Ş; Kök Mİ; Erdemir MB; Bostankolu Değirmenci B; Özkurt ZN; Yağcı M
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):586-597. PubMed ID: 37786821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
    Nawas MT; Sanchez-Escamilla M; Devlin SM; Maloy MA; Ruiz JD; Sauter CS; Giralt SA; Perales MA; Scordo M
    Blood Adv; 2022 Nov; 6(22):5898-5907. PubMed ID: 35977079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS
    López-Andrade B; Cunill V; Andreu V; Bento L; Segura-Guerrero M; Moñino A; Iglesias J; Julià MR; Durán MA; Ballester MC; Muncunill J; Sampol A
    Front Immunol; 2024; 15():1353106. PubMed ID: 38550584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.
    Luft T; Wendtner CM; Kosely F; Radujkovic A; Benner A; Korell F; Kihm L; Bauer MF; Dreger P; Merle U
    Front Immunol; 2021; 12():634416. PubMed ID: 34248931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation.
    Shouval R; Fein JA; Shouval A; Danylesko I; Shem-Tov N; Zlotnik M; Yerushalmi R; Shimoni A; Nagler A
    Blood Adv; 2019 Jun; 3(12):1881-1890. PubMed ID: 31221661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.
    Rachakonda SP; Dai H; Penack O; Blau O; Blau IW; Radujkovic A; Müller-Tidow C; Kumar R; Dreger P; Luft T
    J Clin Oncol; 2018 Mar; 36(8):789-800. PubMed ID: 29369699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-based endothelial prophylaxis and outcome after allogeneic stem cell transplantation.
    Pabst C; Schreck N; Benner A; Hegenbart U; Schönland S; Radujkovic A; Schmitt M; Müller-Tidow C; Orsatti L; Dreger P; Luft T
    Eur J Clin Invest; 2023 Feb; 53(2):e13883. PubMed ID: 36199203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study.
    Kalicińska E; Biernat M; Rybka J; Zińczuk A; Janocha-Litwin J; Rosiek-Biegus M; Morawska M; Waszczuk-Gajda A; Drozd-Sokołowska J; Szukalski Ł; Rymko M; Jabłonowska P; Simon K; Wróbel T
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.